More importantly, Casp6 activity is present in the area first affected by AD in brains from aged non-cognitively impaired individuals and the levels of Casp6 activity correlates with impaired cognitive performance in these individuals [34], [36]. This evidence concerns the gene CASP6 and Alzheimer disease.